Based on our preliminary data and published findings, we hypothesize that CCL17/CCR4 signaling modulates the ERK/AP1/SRA pathway to promote M2 polarization, thereby facilitating hematoma clearance and reducing secondary brain injury. Here, CCL17 is linked to hematoma.